在药物敏感结核病中Linezolid的作用
S Ramesh Kumar1, G Narendran2, C Padmapriyadarsini3
1Department of Clinical Research, ICMR-National Institute for Research in Tuberculosis, Madurai unit, Madurai, India.
Journal of infection and public health
|December 1, 2023
概括
使用linezolid缩短结核病治疗对药物敏感结核病 (DSTB) 有希望. 这种方法可能会为当前的长期治疗方案提供更安全,更有效的替代方案.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 结核病 (TB) 仍然是一个重要的全球卫生问题.
- 目前对药物敏感结核病 (DSTB) 的治疗持续时间很长.
- 莱涅佐利德因其在治疗耐药结核病菌株中的有效性越来越受认可.
研究的目的:
- 调查linezolid在缩短DSTB治疗时间方面的潜力.
- 为了评估linezolid在DSTB中的有利的杀菌作用.
- 为了解决在较短的治疗方案中对linezolid的安全性和耐受性的担忧.
主要方法:
- 审查现有关于linezolid在DSTB中使用的研究.
- 分析报告的杀菌作用和安全概况.
- 探索临床试验数据,以更短的时间来确定linezolid的安全性和耐受性.
主要成果:
- 利尼佐利德在DSTB中表现出有利的杀菌作用.
- 临床试验表明,在较短的治疗期内,linezolid的安全性和耐受性.
- 有限的研究探索了线化物用于DSTB,这表明了一个有前途但未被探索的领域.
结论:
- 确定更短时间线索利德治疗方案的安全性和有效性可能会彻底改变DSTB治疗.
- 利尼佐利德为缩短DSTB治疗提供了一个潜在的替代方案.
- 需要进一步的研究来确认linezolid在加速DSTB治疗中的作用.
相关概念视频
Pulmonary Tuberculosis V
181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Pulmonary Tuberculosis I
244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis III
336
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
336
Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis II
242
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
242
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K


